142 related articles for article (PubMed ID: 9771451)
1. Cytokeratin expression in adrenal phaeochromocytomas and extra-adrenal paragangliomas.
Chetty R; Pillay P; Jaichand V
J Clin Pathol; 1998 Jun; 51(6):477-8. PubMed ID: 9771451
[TBL] [Abstract][Full Text] [Related]
2. A comparative immunohistochemical study of phaeochromocytomas and paragangliomas.
Fraga M; García-Caballero T; Antúnez J; Couce M; Beiras A; Forteza J
Histol Histopathol; 1993 Jul; 8(3):429-36. PubMed ID: 8358154
[TBL] [Abstract][Full Text] [Related]
3. Frequency and extent of cytokeratin expression in paraganglioma: an immunohistochemical study of 60 cases from 5 anatomic sites and review of the literature.
Dermawan JK; Mukhopadhyay S; Shah AA
Hum Pathol; 2019 Nov; 93():16-22. PubMed ID: 31442521
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratins expression in paragangliomas of the cauda equina.
Labrousse F; Leboutet MJ; Petit B; Paraf F; Boncoeur-Martel MP; Moreau JJ; Catanzano G
Clin Neuropathol; 1999; 18(4):208-13. PubMed ID: 10442464
[TBL] [Abstract][Full Text] [Related]
5. Histopathology and immunohistochemistry of adrenal medullary tumors and paragangliomas.
McNicol AM
Endocr Pathol; 2006; 17(4):329-36. PubMed ID: 17525481
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors.
Mamilla D; Manukyan I; Fetsch PA; Pacak K; Miettinen M
Hum Pathol; 2020 Sep; 103():72-82. PubMed ID: 32668278
[TBL] [Abstract][Full Text] [Related]
7. Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques.
Kumaki N; Kajiwara H; Kameyama K; DeLellis RA; Asa SL; Osamura RY; Takami H
Endocr Pathol; 2002; 13(2):149-56. PubMed ID: 12165664
[TBL] [Abstract][Full Text] [Related]
8. Paragangliomas of the cauda equina have a distinctive cytokeratin immunophenotype.
Orrell JM; Hales SA
Histopathology; 1992 Nov; 21(5):479-81. PubMed ID: 1280616
[No Abstract] [Full Text] [Related]
9. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
10. Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas.
Lee JP; Hung YP; O'Dorisio TM; Howe JR; Hornick JL; Bellizzi AM
Histopathology; 2017 Oct; 71(4):503-510. PubMed ID: 28464318
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of endothelin-1, endothelin-3 and endothelin receptors in human pheochromocytoma and paraganglioma.
Watanabe K; Hiraki H; Hasegawa H; Tanigawa T; Emura I; Honma K; Shibuya H; Fukuda T; Suzuki T
Pathol Int; 1997 Aug; 47(8):540-6. PubMed ID: 9293534
[TBL] [Abstract][Full Text] [Related]
12. Basic fibroblast growth factor in human pheochromocytoma: a biochemical and immunohistochemical study.
Statuto M; Ennas MG; Zamboni G; Bonetti F; Pea M; Bernardello F; Pozzi A; Rusnati M; Gualandris A; Presta M
Int J Cancer; 1993 Jan; 53(1):5-10. PubMed ID: 8380057
[TBL] [Abstract][Full Text] [Related]
13. Chemodectoma of the cauda equina: case report.
Ilgren EB; Teddy PJ
Clin Neuropathol; 1984; 3(4):148-52. PubMed ID: 6090047
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemistry of paragangliomas--value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis.
Achilles E; Padberg BC; Holl K; Klöppel G; Schröder S
Histopathology; 1991 May; 18(5):453-8. PubMed ID: 1679411
[TBL] [Abstract][Full Text] [Related]
15. Stathmin immunoreactivity in phaeochromocytomas and paragangliomas: differential expression between benign and malignant neoplasms.
Lin WC; Chen SC; Chuang YT; Kuo KL; Huang KH
Asian J Surg; 2011 Jan; 34(1):15-22. PubMed ID: 21515208
[TBL] [Abstract][Full Text] [Related]
16. [Paraganglioma of the cauda equina].
Ugarte Elola AC; Hernández i Vidal A; Viladot i Pericé R; Royo i Salvador M; Pou i Serradell A
Neurologia; 1993 Feb; 8(2):73-7. PubMed ID: 8383986
[TBL] [Abstract][Full Text] [Related]
17. Paraganglioma of the cauda equina: a highly vascular tumour.
Demirçivi Ozer F; Aydin M; Bezircioğlu H; Oran I
J Clin Neurosci; 2010 Nov; 17(11):1445-7. PubMed ID: 20637630
[TBL] [Abstract][Full Text] [Related]
18. Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management.
Foo SH; Chan SP; Ananda V; Rajasingam V
Singapore Med J; 2010 May; 51(5):e89-93. PubMed ID: 20593136
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas.
Lam KY; Lo CY; Wat NM; Luk JM; Lam KS
J Clin Pathol; 2001 Jun; 54(6):443-8. PubMed ID: 11376017
[TBL] [Abstract][Full Text] [Related]
20. Mesenteric Extra-adrenal Paraganglioma - An Unusual Cause of Intermittent Abdominal Pain.
Stinson W; Bjordahl P
S D Med; 2021 Aug; 74(8):376-379. PubMed ID: 34461004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
